Monogram Technologies insider files Form 4 showing 10,000-option grant
Rhea-AI Filing Summary
Monogram Technologies Inc. (MGRM) director Paul Riss reported a grant of 10,000 stock options on 01/08/2025. The options have an exercise price of $2.50 and are shown with an exercisable date of 01/08/2032 and an expiration date of 01/08/2035, covering 10,000 underlying shares. After the reported transaction the filing shows 40,000 shares beneficially owned by the reporting person in a direct form. The form notes the company uses the Black-Scholes-Merton model to value awards and includes the reporting person signature dated 09/30/2025.
Positive
- 10,000 stock options granted to a director, aligning interests with shareholders
- Beneficial ownership increased to 40,000 shares, showing insider stake
Negative
- Exercisable date is 01/08/2032, indicating a long delay before options can be exercised
- Filing lacks detailed vesting conditions, so incremental vesting or performance contingencies are not disclosed
Insights
TL;DR Director received a 10,000-option grant with a multi-year vest/exercise schedule; holdings increased to 40,000 shares.
The grant is explicitly recorded as a non-derivative/derivative reporting of a stock option award with a $2.50 exercise price and stated exercisable and expiration dates. This filing documents insider compensation and ownership that align director incentives with equity performance. The multi-year exercisability implies a long-term vesting/holding horizon, which affects potential timing of share dilution and insider alignment. No cash transactions, sales, or other dispositions are reported.
TL;DR The options grant formalizes long-term equity compensation; exercisability begins in 2032 and expires in 2035.
The record shows standard use of an option award with fair-value determined by Black-Scholes methodology per the issuer note. The long delay to exercisability suggests the award is structured to promote extended retention. The form does not disclose vesting schedule details beyond the exercisable date, nor the grant date-specific vesting triggers, so analysis of acceleration or performance conditions cannot be made from this filing alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 10,000 | $0.00 | -- |
Footnotes (1)
- [object Object]